Himangi Vig

@psitpharmacy.ac.in

Assistant professor
PSIT-Pranveer Singh Institute of Technology (Pharmacy)

Himangi Vig


                  Download Compact PDF  
https://researchid.co/himangivig

RESEARCH, TEACHING, or OTHER INTERESTS

Pharmacology (medical), Pharmacy, Pharmaceutical Science, Research and Theory
17

Scopus Publications

128

Scholar Citations

7

Scholar h-index

6

Scholar i10-index

Scopus Publications

  • The Role of Non-Pharmacological Interventions in Attenuating Anxiety and Stress Symptoms in PTSD: A Systematic Review
    Ankita Wal, Hanish Singh Jayasingh Chellammal, Rakesh Verma, Himangi Vig, Shraddha Mishra, Pranay Wal, Ajay Kumar, Astik Manju Ashesh, Amin Gasmi
    Current Neuropharmacology, 2026
    Introduction/Objective:: Pharmacological treatments for Post-Traumatic Stress Disorder (PTSD), a disorder that affects emotions and mental health and is thought to be therapeutically deficient, either appear to have a number of adverse effects or cause patients to not take their medications as directed. The effectiveness of non-pharmacological treatments for PTSD-related anxiety, depression, and trauma-related discomfort is examined in the current systematic review. Methods:: Fifty-five relevant studies that reported on the randomized controlled trials and metaanalyses published between 2008 and 2025 were found through a thorough search of a total of 12 databases. Mindfulness-Based Stress Reduction (MBSR), Cognitive Behavioral Therapy (CBT), Eye Movement Desensitization and Reprocessing (EMDR), laughter therapy, acupuncture, dietary modifications, and yoga are among the interventions of interest that were studied. Results:: The severity of PTSD symptoms has been reported to be reliably reduced by MBSR, CBT, and EMDR; some trials of MBSR and CBT have shown improvements of up to 45%. Acupuncture, yoga, and laughter therapy all demonstrated positive impacts; the outcomes varied significantly. Dietary and lifestyle changes appeared to help stabilize mental health, but further research is needed. Discussion:: Results highlight the benefits of non-pharmacological therapies as highly effective and preferable PTSD treatment options, especially for individuals who are sensitive to pharmacotherapy. The strongest, most reliable results were obtained by MBSR and CBT in particular, highlighting the significance of cognitive restructuring and present-moment concentration. While nutrition, yoga, acupuncture, and laughter therapy all contributed to stress alleviation or emotional regulation, EMDR was particularly effective at processing memories without the requirement for verbalization. These tactics encourage resilience, self-control, and empowerment, but future research must address methodological variation, sample size, and intervention standardization. Conclusion:: Non-pharmacological approaches offer promising complementary or standalone strategies for PTSD management. Further large-scale, standardized trials are warranted to strengthen the evidence base and optimize treatment protocols.
  • Phytochemical Composition and Mechanistic Pharmacology of the Citrus Genus: Focus on Organic Constituents
    Himangi Vig, Ankita Wal, Preeti Sharma, Jyotsana Dwivedi, Bhagawati Saxena, Nardev Singh, Akash Ved, Suseela Prema, Amin Gasmi
    Current Organic Chemistry, 2026
    The Citrus genus, which includes species such as Citrus medica, Citrus sinensis, Citrus paradisi, Citrus aurantiifolia, Citrus limon, and Citrus reticulata, is a wellrecognized source of diverse bioactive compounds with broad pharmacological significance. These species are rich in flavonoids, polymethoxylated flavones (PMFs), limonoids, carotenoids, and essential oils, each contributing to therapeutic effects such as antioxidant, anti-inflammatory, anticarcinogenic, and neuroprotective activities. This review comprehensively examines the phytochemical landscape and therapeutic potential of major Citrus species, emphasizing the organic structures, molecular mechanisms, and biological functions of their key constituents. Special focus is placed on structure-activity relationships (SAR), metabolic pathways, and cellular targets, including the PI3K/Akt/mTOR, Nrf2/Keap1, and NF-κB signaling axes. Recent advances in extraction techniques (e.g., green solvent technologies, metabolomics-guided screening) and analytical platforms for compound profiling are also discussed. Furthermore, the role of Citrus-derived compounds in modulating oxidative stress, inflammatory mediators, lipid peroxidation, and oncogenic pathways is elucidated. The article critically assesses existing literature, identifies translational gaps, and proposes future directions for the pharmacological development of Citrus phytoconstituents. This synthesis aims to bridge organic chemistry with pharmacognosy by detailing how structural nuances of Citrus bioactives underlie their multifaceted therapeutic profiles, offering significant promise for nutraceutical and pharmaceutical applications.
  • Cardiospermum halicacabum: A Scoping Review on its Phytoactives, Neuroprotective, Anti-Inflammatory, and Antioxidant Potential
    Himangi Vig, Anuradha Mishra, Ankita Wal
    Central Nervous System Agents in Medicinal Chemistry, 2025
    Introduction: Cardiospermum halicacabum, commonly known as balloon vine or love in a puff, is a medicinal plant recognized for its diverse phytoactive compounds. This plant contains various bioactive constituents, including alkaloids like cardiospermin, flavonoids such as quercetin, and triterpenoids, which contribute to its therapeutic properties. This scoping review presents current literature on the neuroprotective, anti-inflammatory, and antioxidant potentials of Cardiospermum halicacabum, along with preclinical findings, patent reports, and commercially accessible formulations and nanoformulations. Method: This scoping review was conducted in accordance with the PRISMA-ScR guidelines. A comprehensive search of Web of Science, PubMed, Embase, Medline, Google Scholar, and Google Patents was conducted (2008–2024) using keywords such as Cardiospermum halicacabum, balloon vine, antioxidant, anti-inflammatory, and neuroprotective. Only English-language, peer-reviewed articles, patents, and commercially available formulations were included. Studies unrelated to the plant’s neuroprotective, anti-inflammatory, or antioxidant mechanisms were excluded. Screening, data extraction, and critical appraisal were performed independently by three reviewers. Result: Studies suggest that Cardiospermum halicacabum exhibits significant neuroprotective effects, potentially due to its antioxidant activity, which protects neuronal cells from oxidative stressinduced damage. The plant's anti-inflammatory properties are well-documented, indicating efficacy in reducing inflammation through mechanisms that modulate cytokine production and inhibit inflammatory pathways. Its antioxidant constituents scavenge free radicals, preventing oxidative damage to cells and tissues that extends its potential applications in managing oxidative stressrelated disorders. Discussion: The findings highlight the promising therapeutic potential of Cardiospermum halicacabum in neuroprotection, anti-inflammatory responses, and oxidative stress management. While preclinical studies support its efficacy, further research, including clinical trials, is required to confirm its pharmacological benefits and optimize its therapeutic applications. The development of nanoformulations suggests an advanced approach to enhancing bioavailability and targeted drug delivery. Conclusion: Cardiospermum halicacabum shows promise as a multifaceted therapeutic agent, particularly in neurological and inflammatory conditions. Due to its antioxidant, anti-inflammatory, and neuroprotective properties, Cardiospermum halicacabum can be considered a potential neuroprotective agent. While preclinical data are encouraging, further clinical trials are necessary to validate its efficacy and safety for human use. Medicinal potential.
  • A Brief Review on Caenorhabditis elegans Role in Modelling Neurodegenerative Disease
    Himangi Vig, Priyanka shukla, Anamika Mishra, Ayushi pal, Ankita Wal
    Central Nervous System Agents in Medicinal Chemistry, 2025
    A small, translucent nematode known as Caenorhabditis elegans, or C. elegans, is frequently utilized as a model organism in biomedical studies. These worms, which are around 1 mm long and feed on bacteria, are usually found in soil. For accessible and effective research on genetics, developmental biology, neuroscience, cell biology, and aging, C. elegans provide an ideal model. Its simplicity, which includes a translucent body and a nervous system with only 302 neurons, makes it possible to see cellular and developmental processes in great detail. Because of its special benefits, the worm Caenorhabditis elegans allows for a thorough characterization of the cellular and molecular processes causing age-related neurodegenerative diseases. This is a general review of the life cycle, experimental methodologies, and the use of C. elegans to model brain diseases, including those related to molecular and genetic factors that cause neurodegenerative diseases. Additionally, we go over how C. elegans is a perfect model organism for studying neurons in instances of prevalent age-related neurodegenerative illnesses due to a combination of its biological traits and new analytical techniques. The literature review process was carried out step-by-step using online search databases such as Web of Science, PubMED, Embase, Google Scholar, Medline, and Google Patents. In the first searches, keywords like C.elegans, disease modelling, and neuroprotective activity were employed. Because of C. elegans's physiological transparency, it is possible to track the development of neurodegeneration in aging organisms by using co-expressed fluorescent proteins. Importantly, a fully characterized connectome provides a unique ability to precisely connect cellular death with behavioural instability or phenotypic diversity in vivo, thus permitting a deep knowledge of the detrimental effect of neurodegeneration on wellbeing. In addition, pharmacological therapies and both forward and reverse gene screening speed up the discovery of modifiers that change neurodegeneration. These chemical-genetic investigations work together to determine important threshold states that either increase or decrease cellular stress in order to unravel related pathways.
  • Artificial Intelligence and Machine Learning-Based Advances in the Management of Neurodegenerative Diseases
    Ankita Wal, Mangla Nand Singh, Himangi Vig, Manoj Kumar Katul, Bommaiah Prakash Kumar, Manukonda Upender Kumar
    Molecular Targets and Therapeutic Interventions Against Neurodegenerative Diseases, 2025
    In recent decades, there has been an increase in the frequency of neurodegenerative illnesses among the elderly population. To describe these disorders, a large body of investigation has been conducted. These days, computational approaches—especially those using artificial intelligence (AI) and machine learning (ML)—are highly helpful in assisting with and enhancing both the diagnostic and illness monitoring processes. The fast expansion of biological data, facilitated by sophisticated experimental tools, has made AI/ML crucial for deriving significant conclusions and enhancing drug development decision-making. Thanks to the developments in AI and ML methods, there has been an unprecedented opportunity for AI/ML-driven solutions to speed up and improve the efficacy of the central nervous system drug development process. We provide a thorough overview of the applications of AI/ML-powered pharmaceutical research for the central nervous system. Following an introduction to the theories and concepts of AI/ML, we have summarized these applications in various neurological illnesses.
  • Naringenin: A Promising Immunomodulator for Anti-inflammatory, Neuroprotective and Anti-cancer Applications
    Sarita Solanki, Himangi Vig, Nidhi Khatri, Bhanu Pratap Singh, Mohammad Shahid Khan, Manish Devgun, Pranay Wal, Ankita Wal
    Anti Inflammatory and Anti Allergy Agents in Medicinal Chemistry, 2025
    Background: Inflammatory, immune, and neurodegenerative diseases constitute a category of persistent and debilitating conditions affecting millions worldwide, with inter-twined pathophysiological pathways. Recent research has spotlighted naturally occurring compounds like naringenin for potential therapeutic applications across multiple ailments. Objective: This review offers an encompassing exploration of naringenin's anti-inflammatory, immune-protective, and neuroprotective mechanisms, elucidating its pharmacological targets, signal transduction pathways, safety profile, and insights from clinical investigations. Methods: Data for this review were amassed through the scrutiny of various published studies via search engines such as PubMed and Google Scholar. Content from reputable publishers including Bentham Science, Taylor and Francis, Nature, PLOS ONE, among others, was referenced. Results: Naringenin exhibits substantial anti-inflammatory effects by restraining the NF-κB signaling pathway. It activates Nrf2, renowned for its anti-inflammatory properties, inducing the release of hemeoxynase-1 by macrophages. Furthermore, naringenin treatment downregulates the expression of Th1 cytokines and inflammatory mediators. It also impedes xanthine oxidase, counteracts reactive oxygen species (ROS), scavenges superoxide radicals, mitigates the accessibility of oxygen-induced K+ erythrocytes, and reduces lipid peroxidation. Naringenin's antioxidant prowess holds promise for addressing neurological conditions. Conclusion: Extensive research has been undertaken to establish the anti-inflammatory, immunomodulatory, and neuroprotective attributes of naringenin across various medical do-mains, lending credence to its pharmacological utility. The principal obstacle to naringenin's adoption as a therapeutic agent remains the dearth of in vivo data. Efforts should focus on rendering naringenin delivery patient-friendly, economically viable, and technologically advanced.
  • Nanotherapeutics in miscellaneous viral infections
    Pranay Wal, Rohini Karuna Karan, Biplob Debnath, Himangi Vig, Charan Singh, Prasanna Shama Khandige, Vandana Sadananda, Gowrish Sadananda, Ankita Wal
    Applications of Nanotherapeutics and Nanotheranostics in Managing Infectious Diseases, 2025
  • Potential Applications of Mitochondrial Therapy with a Focus on Parkinson’s Disease and Mitochondrial Transplantation
    Pranay Wal, Ankita Wal, Himangi Vig, Danish Mahmood, Mohd Masih Uzzaman Khan
    Advanced Pharmaceutical Bulletin, 2024
    Purpose: Both aging and neurodegenerative illnesses are thought to be influenced by mitochondrial malfunction and free radical formation. Deformities of the energy metabolism, mitochondrial genome polymorphisms, nuclear DNA genetic abnormalities associated with mitochondria, modifications of mitochondrial fusion or fission, variations in shape and size, variations in transit, modified mobility of mitochondria, transcription defects, and the emergence of misfolded proteins associated with mitochondria are all linked to Parkinson's disease. Method: This review is a condensed compilation of data from research that have been published between the years of 2014 and 2022, using search engines like Google Scholar, PubMed, and Scopus. Result: Mitochondrial transplantation is a one-of-a-kind treatment for mitochondrial diseases and deficits in mitochondrial biogenesis. The replacement of malfunctioning mitochondria with transplanted viable mitochondria using innovative methodologies has shown promising outcomes as a cure for Parkinson's, involving tissue sparing coupled with enhanced energy generation and lower oxidative damage. Numerous mitochondria-targeted therapies, including mitochondrial gene therapy, redox therapy, and others, have been investigated for their effectiveness and potency. Conclusion: The development of innovative therapeutics for mitochondria-directed treatments in Parkinson's disease may be aided by optimising mitochondrial dynamics. Many neurological diseases have been studied in animal and cellular models, and it has been found that mitochondrial maintenance can slow the death of neuronal cells. It has been hypothesised that drug therapies for neurodegenerative diseases that focus on mitochondrial dysfunction will help to delay the onset of neuronal dysfunction.
  • A Systematic Review of Various In-vivo Screening Models as well as the Mechanisms Involved in Parkinson's Disease Screening Procedures
    Ankita Wal, Pranay Wal, Himangi Vig, Abdul Samad, Madhusmruti Khandai, Sachin Tyagi
    Current Reviews in Clinical and Experimental Pharmacology, 2024
    Background: Parkinson's disease is the second most common neurological ailment. It is also known that it affects practically all other brain components, although only gradually. Animal models are mostly used to test the efficacy of treatment against a specific enzyme and aid in creating a new drug dose. Objective: The purpose of this review is to highlight in vivo Parkinson's disease screening approaches, as well as the mechanism of action of each drug involved in Parkinson's disease development, and discuss the limitations of each model. In addition, it also sheds light on Parkinson's disease genetic models. Methods: The data for the publication was gathered from databases, such as PubMed, Bentham Science, Elsevier, Springer Nature, Wiley, and Research Gate, after a thorough examination of diverse research findings linked to Parkinson’s disease and its screening models. Results: Each chemical or drug has a unique mechanism for causing disease, whether through the production of reactive oxygen species or the blockage of the dopamine receptor. Almost every disease symptom, whether physical or behavioral, is covered by each of the constructed models' unique set of indicators and symptoms. Conclusion: Animal models are typically used to assess a medicine's activity against a specific enzyme and aid in the creation of a new drug dose. The process, restrictions, and mechanisms interfering with the screening, as well as the level of animal suffering, must all be thoroughly reviewed before any model for screening for Parkinson's disease can be implemented.
  • Role of inflammation, angiogenesis and oxidative stress in developing epilepsy
    Pranay Wal, Himangi Vig, Sulaiman Mohammed Alnaseer, Mohd Masih Uzzaman Khan, Arun Kumar Mishra, Tapan Behl
    Targeting Angiogenesis Inflammation and Oxidative Stress in Chronic Diseases Angiogenesis Inflammation and Oxidative Stress in Chronic Diseases, 2024
  • An Insight into the Pathogenesis of Diabetic Cardiomyopathy Along with the Novel Potential Therapeutic Approaches
    Himangi Vig, Ravinandan AP, Hunsur Nagendra Vishwas, Sachin Tyagi, Shruti Rathore, Ankita Wal, Pranay Wal
    Current Diabetes Reviews, 2024
  • A Systematic Review on the Potential Applications of Theranostic Nanoparticles in Diabetes and its Associated Complication Diabetic Neuropathy
    Uddhav Patangia, Kalpita Bhatta, Himangi Vig, Sneh Priya, Ankita Wal, Lalit Kumar Tyagi, Pranay Wal
    Current Nanomedicine, 2024
  • A Detailed Analysis of the Carotenoids and their Derivatives, including their Multiple Health Advantages
    Pranay Wal, Himangi Vig, Riya Khare, Ankita Wal, Gunjan Tondon, Awadh Kishore, Sunil Kumar
    Open Medicinal Chemistry Journal, 2023
  • Treatment of Parkinson's Disease: Current Treatments and Recent Therapeutic Developments
    Ankita Wal, Pranay Wal, Himangi Vig, Nem Kumar Jain, Shruti Rathore, Karthickeyan Krishnan, Ashish Srivastava
    Current Drug Discovery Technologies, 2023
  • Role of Nutraceuticals and Physical Activity in Parkinson's Disease Risk and Lifestyle Management
    Ankita Wal, Pranay Wal, Himangi Vig, Shruti Rathore, Shiv Shanker Pandey, Nem Kumar Jain, Ashish Srivastava
    Current Aging Science, 2023
  • Conventional treatment options and herbal remedies for male infertility: An overview
    Ankita Wal, Pranay Wal, Ashutosh Pandey, Himangi Vig, Rohini Karunakaran, Biswajit Dash
    Asian Pacific Journal of Reproduction, 2022
  • A Detailed Insight onto the Molecular and Cellular Mechanism of Action of the Antifungal Drugs Used in the Treatment of Superficial Fungal Infections
    Pranay Wal, Nikita Saraswat, Himangi Vig
    Current Drug Therapy, 2022

RECENT SCHOLAR PUBLICATIONS

  • Artificial Intelligence in Phenylketonuria: Bridging Conventional Gaps in Diagnosis and Treatment-A Systematic Review
    Z Nooreen, A Wal, H Vig, N Kumar, RS Suryavanshi, S Goswami
    Reviews on recent clinical trials , 2026
    2026
    Citations: 1
  • Phytochemical Composition and Mechanistic Pharmacology of the Citrus Genus: Focus on Organic Constituents
    H Vig, A Wal, P Sharma, J Dwivedi, B Saxena, N Singh, A Ved, S Prema, ...
    Current Organic Chemistry , 2026
    2026
  • The Role of Non-Pharmacological Interventions in Attenuating Anxiety and Stress Symptoms in PTSD: A Systematic Review
    A Wal, HSJ Chellammal, R Verma, H Vig, S Mishra, P Wal, A Kumar, ...
    Current Neuropharmacology , 2026
    2026
  • Artificial intelligence and machine learning-based advances in the management of neurodegenerative diseases
    A Wal, MN Singh, H Vig, MK Katul, BP Kumar, MU Kumar
    Molecular Targets and Therapeutic Interventions against Neurodegenerative … , 2025
    2025
    Citations: 6
  • Naringenin: A promising immunomodulator for anti-inflammatory, neuroprotective and anti-cancer applications
    S Solanki, H Vig, N Khatri, BP Singh, MS Khan, M Devgun, P Wal, A Wal
    Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 24 (1), 1-25 , 2025
    2025
    Citations: 22
  • Cardiospermum halicacabum : A Scoping Review on its Phytoactives, Neuroprotective, Anti-Inflammatory, and Antioxidant Potential
    H Vig, A Mishra, A Wal
    Central Nervous System Agents in Medicinal Chemistry , 2025
    2025
  • Nanotherapeutics in miscellaneous viral infections
    P Wal, RK Karan, B Debnath, H Vig, C Singh, PS Khandige, V Sadananda, ...
    Applications of Nanotherapeutics and Nanotheranostics in Managing Infectious … , 2025
    2025
  • A Systematic Review on the Potential Applications of Theranostic Nanoparticles in Diabetes and its Associated Complication Diabetic Neuropathy
    U Patangia, K Bhatta, H Vig, S Priya, A Wal, LK Tyagi, P Wal
    Current Nanomedicine (Formerly: Recent Patents on Nanomedicine) 14 (3), 247-265 , 2024
    2024
  • A Brief Review on Caenorhabditis elegans Role in Modelling Neurodegenerative Disease
    H Vig, P Shukla, A Mishra, A Pal, A Wal
    Central Nervous System Agents in Medicinal Chemistry , 2024
    2024
  • A Systematic Review of Various In-vivo Screening Models as well as the Mechanisms Involved in Parkinson's Disease Screening Procedures
    A Wal, P Wal, H Vig, A Samad, M Khandai, S Tyagi
    Current Reviews in Clinical and Experimental Pharmacology Formerly Current … , 2024
    2024
    Citations: 5
  • Role of inflammation, angiogenesis and oxidative stress in developing epilepsy
    P Wal, H Vig, SM Alnaseer, MMU Khan, AK Mishra, T Behl
    Targeting Angiogenesis, Inflammation, and Oxidative Stress in Chronic … , 2024
    2024
    Citations: 2
  • An insight into the pathogenesis of diabetic cardiomyopathy along with the novel potential therapeutic approaches
    H Vig, R AP, HN Vishwas, S Tyagi, S Rathore, A Wal, P Wal
    Current Diabetes Reviews 20 (1), 120-134 , 2024
    2024
    Citations: 15
  • A detailed analysis of the carotenoids and their derivatives, including their multiple health advantages
    P Wal, H Vig, R Khare, A Wal, G Tondon, A Kishore, S Kumar
    The Open Medicinal Chemistry Journal 17 (1) , 2023
    2023
    Citations: 6
  • Role of Nutraceuticals and Physical Activity in Parkinson's Disease Risk and Lifestyle Management
    P Wal, H Vig, A Wal, S Rathore, SS Pandey, NK Jain, A Srivastava
    Current Aging Science 16 (3), 170-187 , 2023
    2023
    Citations: 8
  • Potential applications of mitochondrial therapy with a focus on parkinson’s disease and mitochondrial transplantation
    P Wal, A Wal, H Vig, D Mahmood, MMU Khan
    Advanced Pharmaceutical Bulletin 14 (1), 147 , 2023
    2023
    Citations: 10
  • Treatment of Parkinson's disease: current treatments and recent therapeutic developments
    A Wal, P Wal, H Vig, NK Jain, S Rathore, K Krishnan, A Srivastava
    Current Drug Discovery Technologies 20 (5), 54-70 , 2023
    2023
    Citations: 11
  • Exploring Myasthenia Gravis Subtypes: Impact on Pregnancy and Recent Treatment Advancements
    A Wal, P Wal, A Pandey, H Vig, A Ved, HB Samal
    Interdisciplinary Research in Medical Sciences Specialty 3 (1-2023), 26-38 , 2023
    2023
    Citations: 2
  • Conventional treatment options and herbal remedies for male infertility: An overview
    A Wal, P Wal, A Pandey, H Vig, R Karunakaran, B Dash
    Asian Pacific Journal of Reproduction 11 (4), 158-164 , 2022
    2022
    Citations: 5
  • Detailed insight into the pathophysiology and the behavioral complications associated with the Parkinson's disease and its medications
    P Wal, J Dwivedi, A Wal, H Vig, Y Singh
    Future Journal of Pharmaceutical Sciences 8 (1), 33 , 2022
    2022
    Citations: 18
  • A detailed insight onto the molecular and cellular mechanism of action of the antifungal drugs used in the treatment of superficial fungal infections
    P Wal, N Saraswat, H Vig
    Current Drug Therapy 17 (3), 148-159 , 2022
    2022
    Citations: 11

MOST CITED SCHOLAR PUBLICATIONS

  • Naringenin: A promising immunomodulator for anti-inflammatory, neuroprotective and anti-cancer applications
    S Solanki, H Vig, N Khatri, BP Singh, MS Khan, M Devgun, P Wal, A Wal
    Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 24 (1), 1-25 , 2025
    2025
    Citations: 22
  • Detailed insight into the pathophysiology and the behavioral complications associated with the Parkinson's disease and its medications
    P Wal, J Dwivedi, A Wal, H Vig, Y Singh
    Future Journal of Pharmaceutical Sciences 8 (1), 33 , 2022
    2022
    Citations: 18
  • An insight into the pathogenesis of diabetic cardiomyopathy along with the novel potential therapeutic approaches
    H Vig, R AP, HN Vishwas, S Tyagi, S Rathore, A Wal, P Wal
    Current Diabetes Reviews 20 (1), 120-134 , 2024
    2024
    Citations: 15
  • Treatment of Parkinson's disease: current treatments and recent therapeutic developments
    A Wal, P Wal, H Vig, NK Jain, S Rathore, K Krishnan, A Srivastava
    Current Drug Discovery Technologies 20 (5), 54-70 , 2023
    2023
    Citations: 11
  • A detailed insight onto the molecular and cellular mechanism of action of the antifungal drugs used in the treatment of superficial fungal infections
    P Wal, N Saraswat, H Vig
    Current Drug Therapy 17 (3), 148-159 , 2022
    2022
    Citations: 11
  • Potential applications of mitochondrial therapy with a focus on parkinson’s disease and mitochondrial transplantation
    P Wal, A Wal, H Vig, D Mahmood, MMU Khan
    Advanced Pharmaceutical Bulletin 14 (1), 147 , 2023
    2023
    Citations: 10
  • Role of Nutraceuticals and Physical Activity in Parkinson's Disease Risk and Lifestyle Management
    P Wal, H Vig, A Wal, S Rathore, SS Pandey, NK Jain, A Srivastava
    Current Aging Science 16 (3), 170-187 , 2023
    2023
    Citations: 8
  • Artificial intelligence and machine learning-based advances in the management of neurodegenerative diseases
    A Wal, MN Singh, H Vig, MK Katul, BP Kumar, MU Kumar
    Molecular Targets and Therapeutic Interventions against Neurodegenerative … , 2025
    2025
    Citations: 6
  • A detailed analysis of the carotenoids and their derivatives, including their multiple health advantages
    P Wal, H Vig, R Khare, A Wal, G Tondon, A Kishore, S Kumar
    The Open Medicinal Chemistry Journal 17 (1) , 2023
    2023
    Citations: 6
  • A Systematic Review of Various In-vivo Screening Models as well as the Mechanisms Involved in Parkinson's Disease Screening Procedures
    A Wal, P Wal, H Vig, A Samad, M Khandai, S Tyagi
    Current Reviews in Clinical and Experimental Pharmacology Formerly Current … , 2024
    2024
    Citations: 5
  • Conventional treatment options and herbal remedies for male infertility: An overview
    A Wal, P Wal, A Pandey, H Vig, R Karunakaran, B Dash
    Asian Pacific Journal of Reproduction 11 (4), 158-164 , 2022
    2022
    Citations: 5
  • Evidence-based treatment, assisted by mobile technology to deliver, and evidence-based drugs in South Asian countries
    A Wal, M Khandai, H Vig, P Srivastava, A Agarwal, S Wadhwani, P Wal
    Archives of Pharmacy Practice 13 (4-2022), 63-73 , 2022
    2022
    Citations: 3
  • Role of inflammation, angiogenesis and oxidative stress in developing epilepsy
    P Wal, H Vig, SM Alnaseer, MMU Khan, AK Mishra, T Behl
    Targeting Angiogenesis, Inflammation, and Oxidative Stress in Chronic … , 2024
    2024
    Citations: 2
  • Exploring Myasthenia Gravis Subtypes: Impact on Pregnancy and Recent Treatment Advancements
    A Wal, P Wal, A Pandey, H Vig, A Ved, HB Samal
    Interdisciplinary Research in Medical Sciences Specialty 3 (1-2023), 26-38 , 2023
    2023
    Citations: 2
  • The Structure and Mechanism of Spike Protein, as Well as its Role in Numerous Viral Diseases
    AK Pranay Wal, Ankita Wal, Himangi Vig, Ashish Srivastava
    International Journal of Pharmaceutical Investigation 12 (2) , 2022
    2022
    Citations: 2
  • Artificial Intelligence in Phenylketonuria: Bridging Conventional Gaps in Diagnosis and Treatment-A Systematic Review
    Z Nooreen, A Wal, H Vig, N Kumar, RS Suryavanshi, S Goswami
    Reviews on recent clinical trials , 2026
    2026
    Citations: 1
  • Phytoniosomes: A Phytoplankton-Derived System for Targeted Drug Delivery
    A Wal, H Vig, M Mishra, R Singh, S Rathore, S Tyagi, J Kalita, P Wal
    Pharmacophore 13 (6-2022), 50-60 , 2022
    2022
    Citations: 1
  • Phytochemical Composition and Mechanistic Pharmacology of the Citrus Genus: Focus on Organic Constituents
    H Vig, A Wal, P Sharma, J Dwivedi, B Saxena, N Singh, A Ved, S Prema, ...
    Current Organic Chemistry , 2026
    2026
  • The Role of Non-Pharmacological Interventions in Attenuating Anxiety and Stress Symptoms in PTSD: A Systematic Review
    A Wal, HSJ Chellammal, R Verma, H Vig, S Mishra, P Wal, A Kumar, ...
    Current Neuropharmacology , 2026
    2026
  • Cardiospermum halicacabum : A Scoping Review on its Phytoactives, Neuroprotective, Anti-Inflammatory, and Antioxidant Potential
    H Vig, A Mishra, A Wal
    Central Nervous System Agents in Medicinal Chemistry , 2025
    2025